SCHEMBL8880276

SCHEMBL8880276

O=CC(=O)c1csc(C(F)(F)F)n1

nearest known ligand 0.33

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33
CBLB Q13191 1/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30
IDH1 O75874 1/20 0.30
IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27830260 0.81 ALDH1A1 (0.35) RAF1BRAFCBLBALDH1A1KDM4E
SCHEMBL287556 0.79 KDM4E (0.47) ALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL578096 0.78 KDM4E (0.46) ALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL15356473 0.78 KDM1A (0.41) RAF1BRAFCBLBALDH1A1KDM4E
SCHEMBL6844961 0.78 CBLB (0.35) RAF1BRAFCBLBALDH1A1KDM4E
SCHEMBL3262633 0.78 HTR2B (0.44) CBLBALDH1A1KDM4EGAASMN1; SMN2
Lithium Ion SCHEMBL578095 0.76 PTGER1 (0.36) RAF1BRAFCBLBALDH1A1KDM4E
Ethylene SCHEMBL27344274 0.76 KDM4E (0.44) ALDH1A1KDM4EGAASMN1; SMN2
Trifluoroacetic Acid SCHEMBL27830221 0.75 KDM4E (0.35) RAF1BRAFCBLBALDH1A1KDM4E
SCHEMBL21538999 0.74 GAA (0.36) RAF1BRAFCBLBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5604225-A DIETETICS; OBESITY DR. KARL THOMAE GMBH (DE) 1997-02-18 US disclosed
US-5457205-A Substituted thiazoles useful for treatment of diabetes DR. KARL THOMAE GMBH (DE) 1995-10-10 US disclosed
US-5219852-A Hypoglycemic agents, treatment of diabetes and obesity DR. KARL THOMAE GMBH (DE) 1993-06-15 US disclosed
EP-0239815-B1 SUBSTITUTED THIAZOLES AND OXAZOLES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCESS FOR THEIR PREPARATION Dr. Karl Thomae GmbH (DE) 1991-07-24 EP disclosed
US-4886814-A LOWER BLOOD SUGAR DR. KARL THOMAS GMBH (DE) 1989-12-12 US disclosed
EP-0239815-A1 Substituted thiazoles and oxazoles, medicines containing these compounds and process for their preparation Dr. Karl Thomae GmbH (DE) 1987-10-07 EP disclosed